We also present in vivo evidence showing that emodin significantly repressed TGF-β1 signaling, EMT, fibroblast activation and eventual ECM deposition in the BLM-treated lungs indicating potential therapeutic efficacy of emodin in pulmonary fibrosis. This evidence concerns the gene TGFB1 and pulmonary fibrosis.